727 related articles for article (PubMed ID: 11899146)
1. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
2. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
4. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
[TBL] [Abstract][Full Text] [Related]
5. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in different cutaneous manifestations of lupus erythematosus.
Baima B; Sticherling M
Br J Dermatol; 2001 May; 144(5):958-66. PubMed ID: 11359381
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
8. Localized lymphomatoid papulosis: Unilesional lymphomatoid papulosis, regional lymphomatoid papulosis, and persistent agmination of lymphomatoid papulosis.
Magro CM; Mo JH; Telang G
Clin Dermatol; 2022; 40(6):622-638. PubMed ID: 35907581
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified, associated with lymphomatoid papulosis after a 9-year follow up: A case report.
Muraoka K; Fujimoto M; Iwahashi Y; Matsuzaki I; Yonei N; Murata SI; Jinnin M
J Dermatol; 2020 Jun; 47(6):641-645. PubMed ID: 32323371
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily.
Paulli M; Berti E; Boveri E; Kindl S; Bonoldi E; Gambini C; Rosso R; Borroni G; Straccapansa V; Magrini U; DeCoteau JE; Krammer PH; Möller P; Kadin ME
Hum Pathol; 1998 Nov; 29(11):1223-30. PubMed ID: 9824099
[TBL] [Abstract][Full Text] [Related]
11. Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells.
Zhang CL; Kamarashev J; Qin JZ; Burg G; Dummer R; Döbbeling U
J Pathol; 2003 Jun; 200(2):249-54. PubMed ID: 12754746
[TBL] [Abstract][Full Text] [Related]
12. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.
Ni X; Zhang C; Talpur R; Duvic M
J Invest Dermatol; 2005 Apr; 124(4):741-50. PubMed ID: 15816832
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis.
Cordel N; Tressières B; D'Incan M; Machet L; Grange F; Estève É; Dalac S; Ingen-Housz-Oro S; Bagot M; Beylot-Barry M; Joly P;
Oncologist; 2016 Jan; 21(1):76-83. PubMed ID: 26668250
[TBL] [Abstract][Full Text] [Related]
14. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
15. Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma. A report of two cases and a review of the literature.
McCarty MJ; Vukelja SJ; Sausville EA; Perry JJ; James WD; Jaffe ES; Weiss RB
Cancer; 1994 Dec; 74(11):3051-8. PubMed ID: 7954268
[TBL] [Abstract][Full Text] [Related]
16. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2.
Raqib R; Ekberg C; Sharkar P; Bardhan PK; Zychlinsky A; Sansonetti PJ; Andersson J
Infect Immun; 2002 Jun; 70(6):3199-207. PubMed ID: 12011015
[TBL] [Abstract][Full Text] [Related]
18. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
[TBL] [Abstract][Full Text] [Related]
19. Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
Harvell J; Vaseghi M; Natkunam Y; Kohler S; Kim Y
J Cutan Pathol; 2002 Feb; 29(2):88-92. PubMed ID: 12150138
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD30(+) lymphoproliferative disorders.
Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
